Cadila Healthcare to sell rights of Zypitamagt drug Cadila Healthcare to sell rights of Zypitamagt drug Amir Shaikh / Tuesday, October 1, 2019 0 1255 Article rating: 5.0 Cadila Healthcare on Monday has informed the bourses that it has entered into an agreement with Medicure lnc, a cardiovascular pharmaceutical company to sell its right, title and interest in Zypitamagt (Pitavastatin) Read more
JMC Projects wins orders worth Rs. 560 crore JMC Projects wins orders worth Rs. 560 crore Amir Shaikh / Tuesday, October 1, 2019 0 2946 Article rating: 3.3 As on Q1FY20, the company’s order inflow was at Rs. 1130 crore and total order book was at Rs. 10,173 crore. This translates to book-to-bill of 3.1x giving strong revenue visibility for the next 2-3 years Read more
Natco Pharma gets EIR for its Mekaguda API facility Natco Pharma gets EIR for its Mekaguda API facility Apurva Joshi / Tuesday, October 1, 2019 0 2527 Article rating: 3.0 On Tuesday, Natco Pharma Limited informed the bourses about the successful closure of inspection at its Andhra facility, with the receipt of an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA). Read more
National Peroxide announces temporary shutdown of Kalyan plant National Peroxide announces temporary shutdown of Kalyan plant Amir Shaikh / Tuesday, October 1, 2019 0 2579 Article rating: 4.0 The plant will remain shut down for an approximate period of 90 days. This plant is major revenue driver for the company. During fiscal year 2018-19, it contributed nearly Rs. 420.61 crore to the revenue, representing 95 per cent of total revenue. Read more
Rs.7000 crore capital infusion positive for Bank of Baroda Rs.7000 crore capital infusion positive for Bank of Baroda DSIJ Intelligence / Tuesday, October 1, 2019 0 4101 Article rating: 4.1 The public sector lender, Bank of Baroda has announced capital infusion of Rs. 7000 crore by the Government of India. Read more